NFL Biosciences SA (ALNFL.PA)
1.438 €
-0.12 (-7.58%)
Rating:
Recommendation:
-
| Symbol | ALNFL.PA |
|---|---|
| Price | 1.438 € |
| Beta | 0.000 |
| Volume Avg. | 0.11M |
| Market Cap | 11.640M |
| Shares () | - |
| 52 Week Range | 1.265-3.58 |
| 1y Target Est | - |
| DCF Unlevered | ALNFL.PA DCF -> | |
|---|---|---|
| DCF Levered | ALNFL.PA LDCF -> | |
| ROE | -118.29% | Strong Sell |
| ROA | -102.00% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 9.86% | Neutral |
| P/E | -3.51 | Strong Sell |
| P/B | - |
About
Download (Excel)NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. Its natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and NFL-301, a botanical extract (traditional Chinese medicine) that is in preclinical stage. The company was incorporated in 2006 and is based in Castelnau-le-Lez, France.